Advanced Search

Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Dongfang Liu, Shuo Tian, Kai Zhang, Wei Xiong, Ndongala Michel Lubaki, Zhiying Chen, Weidong Han
2017, 8(12): 861-877. DOI: 10.1007/s13238-017-0415-5
[Abstract] [PDF]
Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung
Hang Cheng, Chengyan Jin, Jing Wu, Shan Zhu, Yong-Jun Liu, Jingtao Chen
2017, 8(12): 878-895. DOI: 10.1007/s13238-017-0379-5
[Abstract] [PDF]
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Zhenguang Wang, Yelei Guo, Weidong Han
2017, 8(12): 896-925. DOI: 10.1007/s13238-017-0400-z
[Abstract] [PDF]
Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
Hua Jiang, Bo Song, Peng Wang, Bizhi Shi, Qixiang Li, Mingliang Fan, Shengmeng Di, Jie Yang, Zonghai Li
2017, 8(12): 926-931. DOI: 10.1007/s13238-017-0472-9
[Abstract] [PDF]
Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung
Hang Cheng,  Chengyan Jin,  Jing Wu,  Shan Zhu,  Yong-Jun Liu,  Jingtao Chen
2017, 8(12): 932-933. DOI: 10.1007/s13238-017-0399-1
[Abstract] [PDF]